Literature DB >> 1624176

Omeprazole versus ranitidine in the treatment of resistant duodenal ulcer.

Z Tulassay, F Szalay, M Acharya.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1624176      PMCID： PMC1379355          DOI： 10.1136/gut.33.6.863

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  2 in total

1.  Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment.

Authors:  G Brunner; W Creutzfeldt; U Harke; R Lamberts
Journal:  Digestion       Date:  1988       Impact factor: 3.216

2.  Double blind multicentre comparison of omeprazole 20 mg once daily versus ranitidine 150 mg twice daily in the treatment of cimetidine or ranitidine resistant duodenal ulcers.

Authors:  J C Delchier; J P Isal; S Eriksson; J C Soule
Journal:  Gut       Date:  1989-09       Impact factor: 23.059
  2 in total
  3 in total

Review 1.  Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis.

Authors:  L B Barradell; D McTavish
Journal:  Pharmacoeconomics       Date:  1993-06       Impact factor: 4.981

Review 2.  Ranitidine: a pharmacoeconomic evaluation of its use in acid-related disorders.

Authors:  J E Frampton; D McTavish
Journal:  Pharmacoeconomics       Date:  1994-07       Impact factor: 4.981

Review 3.  Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.

Authors:  M I Wilde; D McTavish
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.